Get notified when PDSB files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: PDSB PDS Biotechnology Corp 424B4

PDS Biotech files resale prospectus for up to 13.3M shares held by YA II PN, LTD; company gets no proceeds

Filed July 21, 2026 · ~1 min read

Key Changes

  • high

    The prospectus covers resale of up to 13,315,823 shares by selling stockholder YA II PN, LTD, not a primary offering by PDS Biotech.

    The Offering verify on EDGAR →
  • high

    Shares come from a warrant to buy 2,158,274 shares at $1.1824 each and conversion of a $6M promissory note into up to 11,157,549 shares.

    The Offering verify on EDGAR →
  • high

    PDS Biotech will not receive proceeds from resale; it only gets cash if the warrant is exercised for cash.

    The Offering verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (IMMR 10-Q) is open in full — no account needed.

Partner

Trade PDSB commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 1, 2026 · How we verify